PRODUCT

Introduction to Boryung
caring for people’s health

Main Products

A guide to Boryung’ main
products.

Products

A guide to all
Boryung’s products.

close

R&D

The Boryung Company,
envisioning a world with a
healthy mankind.

R&D Vision·Strategy

Boryung’ goal is to develop
into a global company.

Pipeline

The research team at Boryung
aims to lead the future of the
pharmaceutical industry.

close

Investors

The Boryung Company,
envisioning a world with a
healthy mankind.

Financial Information

You can see Boryung’s financial
information.

Stock Information

You can see Boryung’s stock price
information

close

GLOBAL
BUSINESS

An introduction of
Boryung’ global business.

Introduction

The best global company.

CMO

Introducing BRCMO business

Network

50 markets and 150 partners worldwide.

close

PR

An introduction of Boryung ’ value -
Envisioning a healthy mankind.

Advertising

An introduction of video
and printed advertisements of Boryung.

close

Directions

An introduction of Boryung
Pharmaceutical’ value - Envisioning
a healthy mankind.

Directions

An introduction of video
and printed advertisements of Boryung.

close

Introduction

The Best Global Company

Global Business Division

Boryung entered the global market in 1977 by exporting to Germany and later began exporting antibiotics to Mexico in 1980.
The company has had steady growth in overseas markets ever since.

We currently export to almost 50 countries on six continents, including Japan, China, Southeast Asia, the Middle East, Europe, South America, and Africa.
Our main export items are Kanarb (ARB), Kanarb Plus (ARB+HCTZ), Dukarb (ARB+CCB), Tuvero (ARB+Statin), Besto (H2RA), Gelfos M (Antacids) and other prescription drugs, as well as other antibiotics, cancer drugs, and API.

The Global Business Division has created a new model of global business using our outstanding products, extensive experience, diverse strategy, and trusted. partnerships

TOP